Skip to content
The Policy VaultThe Policy Vault

modafinilCareFirst (Caremark)

Excessive sleepiness associated with narcolepsy

Initial criteria

  • The requested drug is being prescribed by, or in consultation with, a sleep specialist.
  • The diagnosis is confirmed by sleep study.

Reauthorization criteria

  • The patient has achieved or maintained a positive response to treatment from baseline.

Approval duration

12 months